Navigation Links
Bio-Organic Catalyst, Inc. Forms Joint Venture With SIF ICAP Mexico S.A. de C.V. as Exclusive Distribution Hub for Central America, Mexico and Caribbean.
Date:10/27/2009

NEW YORK, Oct. 27 /PRNewswire-FirstCall/ -- International Daleco Corporation (Pink Sheets: ILDO) announces its subsidiary, Bio-Organic Catalyst, Inc., has formed a new joint venture company, ICAP Bio Organic, S. de R.L. de C.V., as the distribution hub of its patented and proprietary bio-organic catalyst compositions (BOCs) within Central America, Mexico and Caribbean markets, as well as developing carbon reduction and renewable energy credit opportunities where available.

SIF ICAP Mexico S.A. de C.V. (http://www.sif.com.mx) is a subsidiary of the Mexican Stock Exchange (BMV) and ICAP PLC. SIF ICAP Mexico S.A. de C.V. is the largest company of this kind in Mexico and offers the broadest range of services to banks, brokerage firms, pension funds, mutual funds, corporate treasury departments and government agencies to perform their daily transactions in the fixed-income, OTC derivatives and the foreign exchange markets by using the most advanced and secure information technologies."

ICAP PLC (http://www.icap.com) is the world's premier voice and electronic interdealer broker, delivering specialist intermediary brokering services to trading professionals in the wholesale financial markets. ICAP's businesses currently operate in more than 32 countries and with over 4,300 staff worldwide.

Bio-Organic Catalyst, Inc. (www.bio-organic.com) has a proprietary trademarked product line of patented bio-organic catalyst compositions (BOCs) for advanced upgrade optimization to the systems used to treat wastewater and solid wastes, with installations in industrial and municipal facilities worldwide.

International Daleco Corporation (http://www.interdaleco.com) has financed advanced technology ventures for over 25 years. For the past decade, its primary focus has been on the revolutionary advancements Bio-Organic Catalyst, Inc. brings to the transformation of water treatment and renewable energy systems.

This News Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on the Company's expectations of forecasts of future events, can be affected by inaccurate assumptions and are subject to various risks and known and unknown uncertainties, a number of which are beyond the Company's control. Therefore, actual results could differ materially from the forward-looking statements herein.

Contact: President of International Daleco Corporation and Bio-Organic Catalyst, Inc. Parker D. Dale 917-833-1584

SOURCE International Daleco Corporation


'/>"/>
SOURCE International Daleco Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
2. Boston Scientifics Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network
3. Santaris Pharma A/S Forms Strategic Alliance With Shire plc to Develop RNA-Based Medicines for the Treatment of Rare Genetic Disorders
4. Laser technology creates new forms of metal and enhances aircraft performance
5. Surgeon Performs First Single Incision Peri-Umbilical Laparoscopic Surgery in the State of Missouri
6. Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare
7. Aesthera Announces ANVISA Clearance to Market Photopneumatic Platforms in Brazil
8. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
9. Newbridge Securities Corporation Forms BioVentures Division
10. Cordex Pharma Forms Heart Failure Medical Advisory Board
11. NASDAQ OMX AeA Illinois Tech Index Outperforms Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... WARRINGTON, Pa. , Feb. 3, 2016 /PRNewswire/ ... biotechnology company focused on developing aerosolized KL4 surfactant ... Board of Directors has approved an inducement award ... Craig Fraser , its newly appointed President and ... the Board,s Compensation Committee on February 1, 2016 ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered organ ... and bronchus, today announced that CEO Jim ... CEO & Investor Conference on Tuesday, February ... New York City . HART,s presentation ...
(Date:2/3/2016)... (PRWEB) , ... February 03, 2016 , ... ... validating a series of potential targets (epitopes) specific to misfolded, propagating strains of ... to create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from the ...
Breaking Biology Technology:
(Date:2/3/2016)... -- --> --> ... Identification System Market by Component (Hardware and Software), Search ... Government, Healthcare, and Transportation) and Geography - Global Forecast ... to be worth USD 8.49 Billion by 2020 at ... The transformation and technology evolution from the manual process ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... VIEW, Calif. , Feb. 2, 2016 /PRNewswire/ ... retinopathy market, Frost & Sullivan recognizes US-based Intelligent ... America Frost & Sullivan Award for New Product ... provider in North America , ... in the rapidly growing diabetic retinopathy market. The ...
Breaking Biology News(10 mins):